| Psyllium extracts decreased neoplastic phenotypes induced by the Ha-Ras oncogene transfected into a rat liver oval cell line. | liver, |
| Normal and Ha-ras-1 oncogene transformed Buffalo rat liver (BRL) cells show differential resistance to cytoskeletal protein inhibitors. | liver, |
| Rapid induction of skin and mammary tumors in human c-Ha-ras proto-oncogene transgenic rats by treatment with 7,12-dimethylbenz[a]anthracene followed by 12-O-tetradecanoylphorbol 13-acetate. | skin, |
| The role of RAS oncogene in survival of patients with lung cancer: a systematic review of the literature with meta-analysis. | lung, |
| H-Ras oncogene counteracts the growth-inhibitory effect of genistein in T24 bladder carcinoma cells. | bladder, |
| Influence of the H-ras oncogene on radiation responses of a rat rhabdomyosarcoma cell line. | sarcoma, |
| HRAS oncogene could play an important role in the development of cervical cancer, in addition to the presence of HPV, by reducing the G1 phase and accelerating the G1/S transition of infected cells | cervical, |
| Effects of HRAS oncogene on cell cycle progression in a cervical cancer-derived cell line. | cervical, |
| Oncoprotein expression and morphological phenotypes of human breast epithelial cells transformed by the c-Ha-ras oncogene. | breast, |
| An animal model for the rapid induction of tongue neoplasms in human c-Ha-ras proto-oncogene transgenic rats by 4-nitroquinoline 1-oxide: its potential use for preclinical chemoprevention studies. | neoplasm,tongue, |
| Lack of urinary bladder carcinogenicity of sodium L-ascorbate in human c-Ha-ras proto-oncogene transgenic rats. | bladder, |
| Oncogenic RAS activity is directly responsible for OPCML promoter hypermethylation & epigenetic gene silencing. Elevation of the RAS signaling pathway may play an important role in epigenetic inactivation of OPCML in human epithelial ovarian cancer. | ovarian, |
| Correlation of mutations of oncogene C-Ha-ras at codon 12 with metastasis and survival of gastric cancer patients. | gastric, |
| Targeted activation of a human oncogenic-ras transgene in rat pancreas can induce carcinomas correspondent to human pancreatic ductal adenocarcinomas. | pancreatic, |
| Rapid induction of skin tumors in human but not mouse c-Ha-ras proto-oncogene transgenic mice by chemical carcinogenesis. | skin, |
| Polymorphism of the human Ha-ras oncogene locus in chronic lymphocytic and chronic myelogenous leukemia. | leukemia, |
| [The role of the constitutional features and rearrangement of the H-ras 1 oncogene in the development of human lung cancer]. | lung, |
| Partial transformation of human thyroid epithelial cells by mutant Ha-ras oncogene. | thyroid, |
| Hyperactivation of Ha-ras oncogene, but not Ink4a/Arf deficiency, triggers bladder tumorigenesis. | bladder, |
| Possible enhancing activity of diacylglycerol on 4-nitroquinoline 1-oxide induced carcinogenesis of the tongue in human c-Ha-ras proto-oncogene transgenic rats. | tongue, |